Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
PURPOSE: During a global pandemic, the benefit of routine visits and treatment of patients with cancer must be weighed against the risks to patients, staff, and society. Prostate cancer is one of the most common cancers radiation oncology departments treat, and efficient resource utilization is essential in the setting of a pandemic. Herein, we aim to establish recommendations and a framework by which to evaluate prostate radiation therapy management decisions. METHODS AND MATERIALS: Radiation oncologists from the United States and the United Kingdom rapidly conducted a systematic review and agreed upon recommendations to safely manage patients with prostate cancer during the COVID-19 pandemic. A RADS framework was created: remote visits, and avoidance, deferment, and shortening of radiation therapy was applied to determine appropriate approaches. RESULTS: Recommendations were provided by the National Comprehensive Cancer Network risk group regarding clinical node-positive, postprostatectomy, oligometastatic, and low-volume M1 disease. Across all prostate cancer stages, telemedicine consultations and return visits were recommended when resources/staff available. Delays in consultations and return visits of between 1 and 6 months were deemed safe based on stage of disease. Treatment can be avoided or delayed until safe for very low, low, and favorable intermediate-risk disease. Unfavorable intermediate-risk, high-risk, clinical node-positive, recurrence postsurgery, oligometastatic, and low-volume M1 disease can receive neoadjuvant hormone therapy for 4 to 6 months as necessary. Ultrahypofractionation is preferred for localized, oligometastatic, and low-volume M1, and moderate hypofractionation is preferred for postprostatectomy and clinical node positive disease. Salvage is preferred to adjuvant radiation. CONCLUSIONS: Resources can be reduced for all identified stages of prostate cancer. The RADS (remote visits, and avoidance, deferment, and shortening of radiation therapy) framework can be applied to other disease sites to help with decision making in a global pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951
Dearnaley, D., Syndikus, I., Mossop, H., Khoo, V., Birtle, A., Bloomfield, D., Graham, J., Kirkbride, P., Logue, J., Malik, Z., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30102-4 · Cited by 1,339
Self-citation
Cited by
Telehealth utilization during the Covid-19 pandemic: a systematic review
Garfan, S., Alamoodi, A. H., Zaidan, B. B., Al-Zobbi, M., Hamid, R. A., Alwan, J. K., Ahmaro, I. Y. Y., Khalid, E. T., Jumaah, F. M., Albahri, O. S., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104878 · Cited by 369
Paterson, C., Bacon, R., Dwyer, R., Morrison, K. S., Toohey, K., O'Dea, A., Slade, J., Mortazavi, R., Roberts, C., Pranavan, G., et al. (2020) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2020.151090 · Cited by 139
Kronenfeld, J. P., & Penedo, F. J. (2021) · Translational Behavioral Medicine · doi:10.1093/tbm/ibaa105 · Cited by 93
Desideri, I., Pilleron, S., Battisti, N. M. L., Gomes, F., de Glas, N., Neuendorff, N. R., Liposits, G., Paredero-Pérez, I., Lok, W. C. W., Loh, K. P., et al. (2020) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.05.001 · Cited by 33
Metadata
- Authors
- Zaorsky, N. G., Yu, J. B., McBride, S. M., Dess, R. T., Jackson, W. C., Mahal, B. A., Chen, R., Choudhury, A., Henry, A., Syndikus, I., Mitin, T., Tree, A., Kishan, A. U., & Spratt, D. E.
- Venue
- Advances in Radiation Oncology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 5
- Issue
- 4
- Pages
- 659-665
- ISSN
- 2452-1094 (ISSN-L)
- OpenAlex
- W3013800047
- Cited by
- 175
- References
- 3
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. https://app.cochat.ai/papers/10.1016/j.adro.2020.03.010
- The paper
- Zaorsky, N. G., Yu, J. B., McBride, S. M., Dess, R. T., Jackson, W. C., Mahal, B. A., Chen, R., Choudhury, A., Henry, A., Syndikus, I., Mitin, T., Tree, A., Kishan, A. U., & Spratt, D. E. (2020). Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Advances in Radiation Oncology. https://doi.org/10.1016/j.adro.2020.03.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.